8247.HK Stock Analysis
82
Uncovered
Biosino Bio-Technology and Science Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Biosino Bio-Technology & Science, Inc. engages in the manufacture, sale, and distribution of in-vitro diagnostic reagents and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 421 full-time employees. The company went IPO on 2006-02-27. The Company’s products include mono diagnostic reagent products and double diagnostic reagent products. Its products categories include liver diseases category, kidney diseases category, lipid diseases category, cardiovascular diseases category, glycometabolism category, inorganic ion category, pancreas diseases category and specific protein category. Its products are sold to hospitals and medical institutions.